Skip to content
Biodatica
Start free

Investigator

Shan Zha

GORDON RESEARCH CONFERENCES · funded by NCI

Companies
1

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Mar 1, 2011

Latest Feb 18, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    2026 DNA Damage, Mutation and Cancer Gordon Research Conference and Gordon Research Seminar

    $8k

    Feb 18, 2026NCIGORDON RESEARCH CONFERENCESNIH RePORTER · 11309453 (opens the source filing in a new tab)

  2. R01

    The role of HPF1 in radiation and genotoxic cancer therapy

    $607k

    Jun 7, 2024NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11110388 (opens the source filing in a new tab)

  3. R01

    The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression

    $498k

    Jul 1, 2022NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11127389 (opens the source filing in a new tab)

  4. R01

    The non-catalytic function of PARP2 in DNA repair and cancer therapy

    $592k

    Jul 1, 2022NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11126568 (opens the source filing in a new tab)

  5. R01

    The role of ATM in the suppression of lymphoid malignancy

    $430k

    Mar 1, 2011NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11164715 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources